{"id":1098,"date":"2020-08-26T09:33:00","date_gmt":"2020-08-26T09:33:00","guid":{"rendered":"https:\/\/clinlabint.3wstaging.nl\/marker-genes-reveal-deadly-secrets-of-idiopathic-pulmonary-fibrosis\/"},"modified":"2021-01-08T11:09:36","modified_gmt":"2021-01-08T11:09:36","slug":"marker-genes-reveal-deadly-secrets-of-idiopathic-pulmonary-fibrosis","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/marker-genes-reveal-deadly-secrets-of-idiopathic-pulmonary-fibrosis\/","title":{"rendered":"&#8220;Marker genes&#8221; reveal deadly secrets of Idiopathic Pulmonary Fibrosis"},"content":{"rendered":"<div>Researchers cracked the complete genetic code of individual cells in healthy and diseased human lung tissues to find potential new molecular targets for diagnosing and treating the lethal lung disease Idiopathic Pulmonary Fibrosis (IPF).<\/div>\n<div>A team of scientists from Cincinnati Children\u2019s Hospital Medical Center, in collaboration with investigators at Cedars-Sinai Medical Center in Los Angeles, have published their findings.<\/div>\n<div>\u201cThis paper identifies a number of novel targets and molecular pathways for IPF, for which there are pharmaceutical approaches,\u201d said Jeffrey Whitsett, MD, lead investigator and co-director of the Perinatal Institute at Cincinnati Children\u2019s. \u201cAirway cells can be obtained by brushing the airway or biopsy, and marker genes can be tested to make a diagnosis or monitor treatment.\u201d<\/div>\n<div>IPF is a common and lethal interstitial lung disease in adults, which means it inflames, scars and reconfigures lung tissues. This causes loss of alveoli, where oxygen and carbon dioxide are normally exchanged. Similar losses of lung function can occur earlier in life, especially in children with diseases caused by mutations in genes critical for surfactant and maintenance of the lung saccules.&nbsp;<\/div>\n<div>Biological processes controlling the formation and function of the lung\u2019s alveolar region require precisely orchestrated interactions between diverse epithelial, stromal and immune cells, according to study authors. Despite many years of extensive laboratory studies of whole tissue samples \u2013 trying to identify genetic, cellular and molecular processes that fuel lung ailments like IPF \u2013 the precise biology has remained elusive. &nbsp; &nbsp; &nbsp;<\/div>\n<div>To overcome this, Whitsett and colleagues \u2013 including first author and bioinformatician Yan Xu, PhD of Cincinnati Children\u2019s \u2013 conducted what they believe to be the first-ever single-cell RNA sequence analysis of normal and diseased human lung tissues (all donated with prior informed consent). This provided the authors with a detailed genetic blueprint of all the different epithelial cell types involved in IPF progression and a window to identify aberrant biological processes driving inflammation and fibrosis.<\/div>\n<div>Analysis of normal lung epithelial cells found gene patterns linked to fully formed alveolar type 2 lung cells (AT2 cells), which are important for the production of surfactant, a substance containing a complex of proteins critical to breathing.<\/div>\n<div>Analysis of diseased IPF cells found genetic markers for lung cells that were in indeterminate states of formation, the authors report. IPF cells had lost the normal genetic control systems needed to guide their functions. This study identifies abnormalities in gene expression that can be targeted for therapy of chronic lung diseases like IPF.&nbsp;<\/p>\n<\/div>\n<div>Cincinnati Children\u2019s Hospital<\/div>\n<div><link http:\/\/tinyurl.com\/jlosrsk _blank external-link-new-window \"Opens internal link in current window\">http:\/\/tinyurl.com\/jlosrsk<\/link><\/div>\n<div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Researchers cracked the complete genetic code of individual cells in healthy and diseased human lung tissues to find potential new molecular targets for diagnosing and treating the lethal lung disease Idiopathic Pulmonary Fibrosis (IPF). A team of scientists from Cincinnati Children\u2019s Hospital Medical Center, in collaboration with investigators at Cedars-Sinai Medical Center in Los Angeles, [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[35],"tags":[],"class_list":["post-1098","post","type-post","status-publish","format-standard","hentry","category-e-news"],"_links":{"self":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/1098"}],"collection":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/comments?post=1098"}],"version-history":[{"count":0,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/1098\/revisions"}],"wp:attachment":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media?parent=1098"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/categories?post=1098"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/tags?post=1098"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}